EARLY SYMPTOMATIC IMPROVEMENT with MIRIKIZUMAB INDUCTION THERAPY in PATIENTS with MODERATELY to SEVERELY ACTIVE CROHN'S DISEASE: RESULTS from the PHASE 3 VIVID-1 STUDY

Authors
Category Primary study
Conference32nd United European Gastroenterology Week 2024
Year 2024
This article has no abstract
Epistemonikos ID: 179aaa83558e858bd704252cde5e571c2d17c535
First added on: Feb 16, 2026